-
1
-
-
0036488531
-
Endocrine-responsive breast cancer and strategies for combating resistance
-
Ali S, Coombes R (2002) Endocrine-responsive breast cancer and strategies for combating resistance. Nature Rev 2:101-112
-
(2002)
Nature Rev
, vol.2
, pp. 101-112
-
-
Ali, S.1
Coombes, R.2
-
2
-
-
0016740410
-
Oestrogen responsive human breast cancer in long term tissue culture
-
5518
-
Lippman M, Bolan G (1975) Oestrogen responsive human breast cancer in long term tissue culture. Nature 256(5518):592-593
-
(1975)
Nature
, vol.256
, pp. 592-593
-
-
Lippman, M.1
Bolan, G.2
-
3
-
-
0018175970
-
Estrogen control of progesterone receptor in human breast cancer: Role of estradiol and antiestrogen
-
Horwitz K, Koseki Y, McGuire W (1978) Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology 103:1742-1751
-
(1978)
Endocrinology
, vol.103
, pp. 1742-1751
-
-
Horwitz, K.1
Koseki, Y.2
McGuire, W.3
-
4
-
-
0038688478
-
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases
-
Bardou V, Arpino G, Elledge R, Osborne C, Clark G (2003) Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol 21:1973-1979
-
(2003)
J Clin Oncol
, vol.21
, pp. 1973-1979
-
-
Bardou, V.1
Arpino, G.2
Elledge, R.3
Osborne, C.4
Clark, G.5
-
5
-
-
0030757825
-
Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast
-
14
-
Holland P, Knox W, Potten C, Howell A, Anderson E, Baildam A, Bundred N (1997) Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. J Natl Cancer Inst 89(14):1059-1065
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 1059-1065
-
-
Holland, P.1
Knox, W.2
Potten, C.3
Howell, A.4
Anderson, E.5
Baildam, A.6
Bundred, N.7
-
6
-
-
0031597992
-
The loss of estrogen and progesterone receptor gene expression in human breast cancer
-
Lapidus R, Nass S, Davidson N (1998) The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol Neoplasia 3:85-94
-
(1998)
J Mammary Gland Biol Neoplasia
, vol.3
, pp. 85-94
-
-
Lapidus, R.1
Nass, S.2
Davidson, N.3
-
7
-
-
0032145441
-
Altered estrogen receptor alpha and beta mRNA expression during human breast tumorigenesis
-
Leygue E, Dotzlaw H, Watson P, Murphy L (1998) Altered estrogen receptor alpha and beta mRNA expression during human breast tumorigenesis. Cancer Res 58:3197-3201
-
(1998)
Cancer Res
, vol.58
, pp. 3197-3201
-
-
Leygue, E.1
Dotzlaw, H.2
Watson, P.3
Murphy, L.4
-
8
-
-
0033876197
-
Estrogen receptor beta is coexpressed with ER alpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer
-
Jarvinen T, Pelto-Huikko M, Holli K, Isola J (2000) Estrogen receptor beta is coexpressed with ER alpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol 156:29-35
-
(2000)
Am J Pathol
, vol.156
, pp. 29-35
-
-
Jarvinen, T.1
Pelto-Huikko, M.2
Holli, K.3
Isola, J.4
-
9
-
-
0345382876
-
Involvement of estrogen receptor b in terminal differentiation of mammary gland epithelium
-
24
-
Forster C, Makela S, Warri A, Kietz S, Becker D, Hultenby K, Warner M, Gustafsson J (2002) Involvement of estrogen receptor b in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci U S A 99(24):15578-15583
-
(2002)
Proc Natl Acad Sci U S a
, vol.99
, pp. 15578-15583
-
-
Forster, C.1
Makela, S.2
Warri, A.3
Kietz, S.4
Becker, D.5
Hultenby, K.6
Warner, M.7
Gustafsson, J.8
-
10
-
-
0033304993
-
The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
-
Hall J, McDonnell D (1999) The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140:5566-5578
-
(1999)
Endocrinology
, vol.140
, pp. 5566-5578
-
-
Hall, J.1
McDonnell, D.2
-
11
-
-
0034705032
-
Estrogen receptor (ER) b, a modulator of ERa in the uterus
-
11
-
Weihua Z, Saji S, Makinen S, Cheng G, Jensen E, Warner M, Gustaffson J-A (2000) Estrogen receptor (ER) b, a modulator of ERa in the uterus. Proc Natl Acad Sci 97(11):5936-5941
-
(2000)
Proc Natl Acad Sci
, vol.97
, pp. 5936-5941
-
-
Weihua, Z.1
Saji, S.2
Makinen, S.3
Cheng, G.4
Jensen, E.5
Warner, M.6
Gustaffson, J.-A.7
-
12
-
-
0035866760
-
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors
-
Roger P, Sahla M, Makela S, Gustafsson JA, Baldet P, Rochefort H (2001) Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res 61:2537-2541
-
(2001)
Cancer Res
, vol.61
, pp. 2537-2541
-
-
Roger, P.1
Sahla, M.2
Makela, S.3
Gustafsson, J.A.4
Baldet, P.5
Rochefort, H.6
-
13
-
-
0036262148
-
Oestrogen receptor beta in breast cancer: Good, bad or still too early to tell?
-
2
-
Speirs V (2002) Oestrogen receptor beta in breast cancer: good, bad or still too early to tell? J Pathol 197(2):143-147
-
(2002)
J Pathol
, vol.197
, pp. 143-147
-
-
Speirs, V.1
-
14
-
-
0033083820
-
Coexpression of estrogen receptor alpha and beta: Poor prognostic factors in human breast cancer?
-
3
-
Speirs V, Parkes A, Kerin M, Walton D, Carleton P, Fox J, Atkin S (1999) Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? Cancer Res 59(3):525-528
-
(1999)
Cancer Res
, vol.59
, pp. 525-528
-
-
Speirs, V.1
Parkes, A.2
Kerin, M.3
Walton, D.4
Carleton, P.5
Fox, J.6
Atkin, S.7
-
15
-
-
0035918141
-
Immunochemical detection of Erbeta in breast cancer: Towards more detailed receptor profiling?
-
Skliris G, Carder P, Lansdown M, Speirs V (2001) Immunochemical detection of Erbeta in breast cancer: towards more detailed receptor profiling? Br J Cancer 84:1095-1098
-
(2001)
Br J Cancer
, vol.84
, pp. 1095-1098
-
-
Skliris, G.1
Carder, P.2
Lansdown, M.3
Speirs, V.4
-
16
-
-
0035122520
-
Estrogen receptor beta expression in invasive breast cancer
-
Mann S, Laucirica R, Carlson N, Younes P, Ali N, Younes A, Li Y, Younes M (2001) estrogen receptor beta expression in invasive breast cancer. Hum Pathol 32:113-118
-
(2001)
Hum Pathol
, vol.32
, pp. 113-118
-
-
Mann, S.1
Laucirica, R.2
Carlson, N.3
Younes, P.4
Ali, N.5
Younes, A.6
Li, Y.7
Younes, M.8
-
17
-
-
0037011662
-
Relationship of coregulator and estrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer
-
Murphy L, Leygue E, Niu Y, Snell L, Ho S-M, Watson P (2002) Relationship of coregulator and estrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer. British J Cancer 87:1411-1416
-
(2002)
British J Cancer
, vol.87
, pp. 1411-1416
-
-
Murphy, L.1
Leygue, E.2
Niu, Y.3
Snell, L.4
Ho, S.-M.5
Watson, P.6
-
18
-
-
0842291456
-
Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer
-
1
-
Fleming F, Hill A, McDermott E, O'Higgins N, Young L (2004) Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer. J Clin Endocrinol Metab 89(1):375-383
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 375-383
-
-
Fleming, F.1
Hill, A.2
McDermott, E.3
O'Higgins, N.4
Young, L.5
-
19
-
-
4444254432
-
Estrogen receptor beta (ERbeta) level but not its ERbeta-cx variant helps to predict tamoxifen resistance in breast cancer
-
Esslimani-Sahla M, Simony-Lafontaine J, Kramar A, Lavaill R, Mollevi C, Warner M, Gustafsson J-A, Rochefort H (2004) Estrogen receptor beta (ERbeta) level but not its ERbeta-cx variant helps to predict tamoxifen resistance in breast cancer. Clin Cancer Res 10:5769-5776
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5769-5776
-
-
Esslimani-Sahla, M.1
Simony-Lafontaine, J.2
Kramar, A.3
Lavaill, R.4
Mollevi, C.5
Warner, M.6
Gustafsson, J.-A.7
Rochefort, H.8
-
20
-
-
9344264630
-
Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer
-
22
-
Hopp T, Weiss H, Parra I, Cui Y, Osborne C, Fuqua S (2004) Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 10(22):7490-7499
-
(2004)
Clin Cancer Res
, vol.10
, pp. 7490-7499
-
-
Hopp, T.1
Weiss, H.2
Parra, I.3
Cui, Y.4
Osborne, C.5
Fuqua, S.6
-
21
-
-
0042326176
-
Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer
-
1
-
Iwase H, Zhang Z, Omoto Y, Sugiura H, Yamashita H, Toyama T, Iwata H, Kobayashi S (2003) Clinical significance of the expression of estrogen receptors alpha and beta for endocrine therapy of breast cancer. Cancer Chemother Pharmacol 52 Suppl (1):S34-38
-
(2003)
Cancer Chemother Pharmacol
, vol.52
, pp. 34-38
-
-
Iwase, H.1
Zhang, Z.2
Omoto, Y.3
Sugiura, H.4
Yamashita, H.5
Toyama, T.6
Iwata, H.7
Kobayashi, S.8
-
22
-
-
9144269004
-
Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine resistant breast cancer
-
Myers E, Fleming F, Crotty T, Kelly G, McDermott E, O'Higgins N, Hill A, Young L (2004) Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrine resistant breast cancer. Br J Cancer 91:1687-1693
-
(2004)
Br J Cancer
, vol.91
, pp. 1687-1693
-
-
Myers, E.1
Fleming, F.2
Crotty, T.3
Kelly, G.4
McDermott, E.5
O'Higgins, N.6
Hill, A.7
Young, L.8
-
23
-
-
2442553813
-
The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer
-
5
-
Nakopoulou L, Panayotopoulou AL, Giannopoulou I, Givalos N, Markaki S, Keramopoulos A (2004) The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer. J Clin Pathol 57(5):523-528
-
(2004)
J Clin Pathol
, vol.57
, pp. 523-528
-
-
Nakopoulou, L.1
Panayotopoulou, A.L.2
Giannopoulou, I.3
Givalos, N.4
Markaki, S.5
Keramopoulos, A.6
-
24
-
-
0035952371
-
Clinical value of the wild-type estrogen receptor beta expression in breast cancer
-
2
-
Omoto Y, Inoue S, Ogawa S, Toyama T, Yamashita H, Muramatsu M, Kobayashi S, Iwase H (2001) Clinical value of the wild-type estrogen receptor beta expression in breast cancer. Cancer Lett 163(2):207-212
-
(2001)
Cancer Lett
, vol.163
, pp. 207-212
-
-
Omoto, Y.1
Inoue, S.2
Ogawa, S.3
Toyama, T.4
Yamashita, H.5
Muramatsu, M.6
Kobayashi, S.7
Iwase, H.8
-
25
-
-
9144226888
-
Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers
-
9
-
O'Neill P, Davies M, Shaaban A, Innes H, Torevell A, Sibson D, Foster C (2004) Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers. Br J Cancer 91(9):1694-1702
-
(2004)
Br J Cancer
, vol.91
, pp. 1694-1702
-
-
O'Neill, P.1
Davies, M.2
Shaaban, A.3
Innes, H.4
Torevell, A.5
Sibson, D.6
Foster, C.7
-
26
-
-
0348107410
-
New insights into estogen receptor function in human breast cancer
-
8
-
Murphy L, Cherlet T, Lewis A, Banu Y, Watson P (2003) New insights into estogen receptor function in human breast cancer. Ann Med 35(8):614-631
-
(2003)
Ann Med
, vol.35
, pp. 614-631
-
-
Murphy, L.1
Cherlet, T.2
Lewis, A.3
Banu, Y.4
Watson, P.5
-
27
-
-
0032423729
-
Steroid hormone receptors in breast cancer management
-
Osborne C (1998) Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat 51:227-238
-
(1998)
Breast Cancer Res Treat
, vol.51
, pp. 227-238
-
-
Osborne, C.1
-
28
-
-
0033744048
-
Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: Correlations with biological character and distinct differences among SRC coactivator family members
-
10
-
Kraichely D, Sun J, Katzenellenbogen J, Katzenellenbogen B (2000) Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinol 141(10):3534-3545
-
(2000)
Endocrinol
, vol.141
, pp. 3534-3545
-
-
Kraichely, D.1
Sun, J.2
Katzenellenbogen, J.3
Katzenellenbogen, B.4
-
29
-
-
17844409085
-
Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells
-
2
-
Murphy L, Peng B, Lewis A, Davie J, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R (2005) Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J Mol Endocrinol 34(2):553-566
-
(2005)
J Mol Endocrinol
, vol.34
, pp. 553-566
-
-
Murphy, L.1
Peng, B.2
Lewis, A.3
Davie, J.4
Leygue, E.5
Kemp, A.6
Ung, K.7
Vendetti, M.8
Shiu, R.9
-
30
-
-
0037447205
-
Psoriasin interacts with Jab1 and influences breast cancer progression
-
Emberley E, Niu Y, Leygue E, Tomes L, Gietz R, Murphy L, Watson P (2003) Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 63:1954-1961
-
(2003)
Cancer Res
, vol.63
, pp. 1954-1961
-
-
Emberley, E.1
Niu, Y.2
Leygue, E.3
Tomes, L.4
Gietz, R.5
Murphy, L.6
Watson, P.7
-
31
-
-
0029844279
-
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma
-
Erratum in: Cancer Res 1997;57:793.
-
Leygue E, Snell L, Hiller H, Dotzlaw H, Hole K, Murphy L, Watson P (1996): Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Erratum in: Cancer Res 1997;57:793. Cancer Res 56:4606-4609
-
(1996)
Cancer Res
, vol.56
, pp. 4606-4609
-
-
Leygue, E.1
Snell, L.2
Hiller, H.3
Dotzlaw, H.4
Hole, K.5
Murphy, L.6
Watson, P.7
-
32
-
-
0030944985
-
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
-
5
-
Serrano M, Lin A, McCurrach M, Beach D, Lowe S (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88(5):593-602
-
(1997)
Cell
, vol.88
, pp. 593-602
-
-
Serrano, M.1
Lin, A.2
McCurrach, M.3
Beach, D.4
Lowe, S.5
-
33
-
-
0029840479
-
The NCIC-Manitoba Breast Tumor Bank: A resource for applied cancer research
-
Watson P, Snell L, Parisien M (1996) The NCIC-Manitoba Breast Tumor Bank: a resource for applied cancer research. CMAJ 155:281-283
-
(1996)
CMAJ
, vol.155
, pp. 281-283
-
-
Watson, P.1
Snell, L.2
Parisien, M.3
-
34
-
-
0032794404
-
Psoriasin (S100A7) expression and invasive breast cancer
-
Al-haddad S, Zhang Z, Leygue E, Snell L, Huang A, Niu Y, Hiller-Hitchcock T, Hole K, Murphy L, Watson P (1999) Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 155:2057-2066
-
(1999)
Am J Pathol
, vol.155
, pp. 2057-2066
-
-
Al-Haddad, S.1
Zhang, Z.2
Leygue, E.3
Snell, L.4
Huang, A.5
Niu, Y.6
Hiller-Hitchcock, T.7
Hole, K.8
Murphy, L.9
Watson, P.10
-
35
-
-
0038155092
-
Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer
-
Emberley E, Niu Y, Njue C, Kliewer E, Murphy L, Watson P (2003) Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin Cancer Res 9:2627-2631
-
(2003)
Clin Cancer Res
, vol.9
, pp. 2627-2631
-
-
Emberley, E.1
Niu, Y.2
Njue, C.3
Kliewer, E.4
Murphy, L.5
Watson, P.6
-
36
-
-
21344437044
-
The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.soriasin (S100A7) stimulates pro-survival pathways through activation of Jab1 in breast cancer
-
13
-
Emberley E, Niu Y, Curtis L, Troup S, Mandal S, Myers J, Gibson S, Murphy L, Watson P (2005) The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.soriasin (S100A7) stimulates pro-survival pathways through activation of Jab1 in breast cancer. Cancer Res 65(13):5696-5702
-
(2005)
Cancer Res
, vol.65
, pp. 5696-5702
-
-
Emberley, E.1
Niu, Y.2
Curtis, L.3
Troup, S.4
Mandal, S.5
Myers, J.6
Gibson, S.7
Murphy, L.8
Watson, P.9
-
37
-
-
0141995803
-
Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyltransferase inhibitors in a cell line model
-
Skliris G, Munot K, Bell S, Carder P, lane S, Horgan K, Lansdown M, Parkes A, Hanby A, Markham A et al (2003) Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyltransferase inhibitors in a cell line model. J Pathol 201:213-220
-
(2003)
J Pathol
, vol.201
, pp. 213-220
-
-
Skliris, G.1
Munot, K.2
Bell, S.3
Carder, P.4
Lane, S.5
Horgan, K.6
Lansdown, M.7
Parkes, A.8
Hanby, A.9
Markham, A.10
-
38
-
-
0027394794
-
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer
-
3
-
Allred D, Clark G, Elledge R, Fuqua S, Brown R, Chamness G, Osborne O, McGuire W (1993) Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85(3):200-206
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 200-206
-
-
Allred, D.1
Clark, G.2
Elledge, R.3
Fuqua, S.4
Brown, R.5
Chamness, G.6
Osborne, O.7
McGuire, W.8
-
39
-
-
0028802976
-
Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22
-
Moog-Lutz C, Bouillet P, Regnier C, Tomasetto C, Mattei M, Chenard M, Anglard P, Rio M, Basset P (1995) Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22. Int J Cancer 63:297-303
-
(1995)
Int J Cancer
, vol.63
, pp. 297-303
-
-
Moog-Lutz, C.1
Bouillet, P.2
Regnier, C.3
Tomasetto, C.4
Mattei, M.5
Chenard, M.6
Anglard, P.7
Rio, M.8
Basset, P.9
-
40
-
-
0036568506
-
C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells
-
1
-
Venditti M, Iwasiow B, Orr F, Shiu R (2002) C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells. Int J Cancer 99(1):35-42
-
(2002)
Int J Cancer
, vol.99
, pp. 35-42
-
-
Venditti, M.1
Iwasiow, B.2
Orr, F.3
Shiu, R.4
-
41
-
-
0036177151
-
Antagonists selective for estrogen receptor alpha
-
3
-
Sun J, Huang Y, Harrington W, Sheng S, Katzenellenbogen J, Katzenellenbogen B (2002) Antagonists selective for estrogen receptor alpha. Endocrinology 143(3):941-947
-
(2002)
Endocrinology
, vol.143
, pp. 941-947
-
-
Sun, J.1
Huang, Y.2
Harrington, W.3
Sheng, S.4
Katzenellenbogen, J.5
Katzenellenbogen, B.6
-
42
-
-
0037692904
-
Carbonic Anhydrase XII is a marker of good prognosis in Invasive Breast Carcinoma
-
Watson P, Chia S, Wykoff C, Han C, Leek R, Sly W, Gatter K, Ratcliffe P, Harris A (2003) Carbonic Anhydrase XII is a marker of good prognosis in Invasive Breast Carcinoma. Br J Cancer 88:1065-1070
-
(2003)
Br J Cancer
, vol.88
, pp. 1065-1070
-
-
Watson, P.1
Chia, S.2
Wykoff, C.3
Han, C.4
Leek, R.5
Sly, W.6
Gatter, K.7
Ratcliffe, P.8
Harris, A.9
-
43
-
-
0037689113
-
Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines
-
1
-
Concin N, Zeillinger C, Tong D, Stimpfl M, Konig M, Printz D, Stonek F, Schneeberger C, Hefler L, Kainz C et al (2003) Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines. Breast Cancer Res Treat 79(1):37-46
-
(2003)
Breast Cancer Res Treat
, vol.79
, pp. 37-46
-
-
Concin, N.1
Zeillinger, C.2
Tong, D.3
Stimpfl, M.4
Konig, M.5
Printz, D.6
Stonek, F.7
Schneeberger, C.8
Hefler, L.9
Kainz, C.10
-
44
-
-
0032566547
-
Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta
-
39
-
Montano M, Jaiswal A, Katzenellenbogen B (1998) Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta. J Biol Chem 273(39):25443-25449
-
(1998)
J Biol Chem
, vol.273
, pp. 25443-25449
-
-
Montano, M.1
Jaiswal, A.2
Katzenellenbogen, B.3
-
45
-
-
0037314762
-
Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice
-
2
-
Lindberg M, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson J, Ohlsson C (2003) Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol Endocrinol 17(2):203-208
-
(2003)
Mol Endocrinol
, vol.17
, pp. 203-208
-
-
Lindberg, M.1
Moverare, S.2
Skrtic, S.3
Gao, H.4
Dahlman-Wright, K.5
Gustafsson, J.6
Ohlsson, C.7
-
46
-
-
0043288096
-
Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta
-
9
-
Otsuki M, Gao H, Dahlman-Wright K, Ohlsson C, Eguchi N, Urade Y, Gustafsson J (2003) Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta. Mol Endocrinol 17(9):1844-1855
-
(2003)
Mol Endocrinol
, vol.17
, pp. 1844-1855
-
-
Otsuki, M.1
Gao, H.2
Dahlman-Wright, K.3
Ohlsson, C.4
Eguchi, N.5
Urade, Y.6
Gustafsson, J.7
-
47
-
-
0038039704
-
Oxytocin, but not oxytocin receptor, is rRegulated by oestrogen receptor beta in the female mouse hypothalamus
-
8
-
Patisaul H, Scordalakes E, Young L, Rissman E (2003) Oxytocin, but not oxytocin receptor, is rRegulated by oestrogen receptor beta in the female mouse hypothalamus. J Neuroendocrinol 15(8):787-793
-
(2003)
J Neuroendocrinol
, vol.15
, pp. 787-793
-
-
Patisaul, H.1
Scordalakes, E.2
Young, L.3
Rissman, E.4
-
48
-
-
0037405088
-
Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells
-
1
-
Cao L, Bu R, Oakley J, Kalla S, Blair H (2003) Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells. J Cell Biochem 89(1):152-164
-
(2003)
J Cell Biochem
, vol.89
, pp. 152-164
-
-
Cao, L.1
Bu, R.2
Oakley, J.3
Kalla, S.4
Blair, H.5
-
49
-
-
0141752761
-
Estrogen rceptor isoform specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ER beta
-
Monroa D, Getz B, Johnsen S, Riggs BL, Khosla S, Spelsberg T (2003) Estrogen rceptor isoform specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ER beta. J Cell Biochem 90:315-326
-
(2003)
J Cell Biochem
, vol.90
, pp. 315-326
-
-
Monroa, D.1
Getz, B.2
Johnsen, S.3
Riggs, B.L.4
Khosla, S.5
Spelsberg, T.6
-
50
-
-
0033592892
-
Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators
-
26
-
An J, Ribeiro R, Webb P, Gustafsson J, Kushner P, Baxter J, Leitman D (1999) Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci U S A 96(26):15161-15166
-
(1999)
Proc Natl Acad Sci U S a
, vol.96
, pp. 15161-15166
-
-
An, J.1
Ribeiro, R.2
Webb, P.3
Gustafsson, J.4
Kushner, P.5
Baxter, J.6
Leitman, D.7
-
51
-
-
18244406327
-
Estrogen receptors and proliferation markers in primary and recurrent breast cancer
-
Jensen E, Cheng G, Palmieri C, Saji S, Makela S, Noorden Sv, Wahlstrom T, Warner M, Coombes R, Gustafsson J-A (2001) Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci U S A 98:15197-15202
-
(2001)
Proc Natl Acad Sci U S a
, vol.98
, pp. 15197-15202
-
-
Jensen, E.1
Cheng, G.2
Palmieri, C.3
Saji, S.4
Makela, S.5
Sv, N.6
Wahlstrom, T.7
Warner, M.8
Coombes, R.9
Gustafsson, J.-A.10
-
52
-
-
23044467159
-
Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity
-
30
-
Lewandowski S, Thiery J, Jalil A, Leclercq G, Szczylik C, Chouaib S (2005) Opposite effects of estrogen receptors alpha and beta on MCF-7 sensitivity to the cytotoxic action of TNF and p53 activity. Oncogene 24(30):4789-4798
-
(2005)
Oncogene
, vol.24
, pp. 4789-4798
-
-
Lewandowski, S.1
Thiery, J.2
Jalil, A.3
Leclercq, G.4
Szczylik, C.5
Chouaib, S.6
-
53
-
-
0034286907
-
Exposure to UVB induces accumulation of LFA-1+ T cells and enhanced expression of the chemokine psoriasin in normal human skin
-
3
-
Nuzzo SD, Sylva-Steenland R, Koomen C, Rie Md, Das P, Bos J, Teunissen M (2000) Exposure to UVB induces accumulation of LFA-1+ T cells and enhanced expression of the chemokine psoriasin in normal human skin. Photochem Photobiol 72(3):374-382
-
(2000)
Photochem Photobiol
, vol.72
, pp. 374-382
-
-
Nuzzo, S.D.1
Sylva-Steenland, R.2
Koomen, C.3
Md, R.4
Das, P.5
Bos, J.6
Teunissen, M.7
-
54
-
-
0036142878
-
Psoriasin expression in mammary epithelial cells in vitro and in vivo
-
Enerback C, Porter D, Seth P, Sgroi D, Gaudet J, Weremowicz S, Morton C, Schnitt S, Pitts R, Stampl J et al (2002) Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res 62:43-47
-
(2002)
Cancer Res
, vol.62
, pp. 43-47
-
-
Enerback, C.1
Porter, D.2
Seth, P.3
Sgroi, D.4
Gaudet, J.5
Weremowicz, S.6
Morton, C.7
Schnitt, S.8
Pitts, R.9
Stampl, J.10
-
55
-
-
1642535535
-
Estrogen receptor b inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest
-
Paruthiyil S, Parmar H, Kerekatte V, Cunha G, Firestone G, Leitman D (2004) Estrogen receptor b inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64:423-428
-
(2004)
Cancer Res
, vol.64
, pp. 423-428
-
-
Paruthiyil, S.1
Parmar, H.2
Kerekatte, V.3
Cunha, G.4
Firestone, G.5
Leitman, D.6
-
56
-
-
0036739344
-
Oestrogen induced apoptosis in colonocytes expressing oestrogen receptor beta
-
Qiu Y, Waters C, Lewis A, Langmann M, Eggo M (2002) Oestrogen induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 174:369-377
-
(2002)
J Endocrinol
, vol.174
, pp. 369-377
-
-
Qiu, Y.1
Waters, C.2
Lewis, A.3
Langmann, M.4
Eggo, M.5
-
57
-
-
0034127791
-
Estrogen receptor protects p53 from deactivation by human double minute-2
-
Liu G, Schwartz J, Brooks S (2000) Estrogen receptor protects p53 from deactivation by human double minute-2. Cancer Res 60:1810-1814
-
(2000)
Cancer Res
, vol.60
, pp. 1810-1814
-
-
Liu, G.1
Schwartz, J.2
Brooks, S.3
-
58
-
-
28544447228
-
BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene
-
Kennedy R, Gorski J, Quinn J, Stewart G, James C, Moore S, Mulligan K, Emberley E, Lioe T, Morrison P et al (2005) BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. Cancer Res 65:10265-10272
-
(2005)
Cancer Res
, vol.65
, pp. 10265-10272
-
-
Kennedy, R.1
Gorski, J.2
Quinn, J.3
Stewart, G.4
James, C.5
Moore, S.6
Mulligan, K.7
Emberley, E.8
Lioe, T.9
Morrison, P.10
-
59
-
-
23844476499
-
P53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest
-
Ho J, Ma W, Mao D, Benchimol S (2005) p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol 25:7423-7431
-
(2005)
Mol Cell Biol
, vol.25
, pp. 7423-7431
-
-
Ho, J.1
Ma, W.2
Mao, D.3
Benchimol, S.4
-
60
-
-
10744223743
-
The prognostic implication of the basal-like (cyclin e high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
-
3
-
Foulkes W, Brunet J, Stefansson I, Straume O, Chappuis P, Begin L, Hamel N, Goffin J, Wong N, Trudel M et al (2004) The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res 64(3):830-835
-
(2004)
Cancer Res
, vol.64
, pp. 830-835
-
-
Foulkes, W.1
Brunet, J.2
Stefansson, I.3
Straume, O.4
Chappuis, P.5
Begin, L.6
Hamel, N.7
Goffin, J.8
Wong, N.9
Trudel, M.10
-
61
-
-
0035933723
-
Tumor suppressor p53 protein is a new target for the metastasis- associated Mts1/S100A4 protein: Functional consequences of their interaction
-
25
-
Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G et al (2001) Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276(25):22699-22708
-
(2001)
J Biol Chem
, vol.276
, pp. 22699-22708
-
-
Grigorian, M.1
Andresen, S.2
Tulchinsky, E.3
Kriajevska, M.4
Carlberg, C.5
Kruse, C.6
Cohn, M.7
Ambartsumian, N.8
Christensen, A.9
Selivanova, G.10
-
62
-
-
23844505646
-
The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity
-
32
-
Mueller A, Schafer B, Ferrari S, Weibel M, Makek M, Hochli M, Heizmann C (2005) The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem 280(32):29186-29193
-
(2005)
J Biol Chem
, vol.280
, pp. 29186-29193
-
-
Mueller, A.1
Schafer, B.2
Ferrari, S.3
Weibel, M.4
Makek, M.5
Hochli, M.6
Heizmann, C.7
-
63
-
-
0035794541
-
COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system
-
7
-
Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, Dubiel W (2001) COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. Embo J 20(7):1630-1639
-
(2001)
Embo J
, vol.20
, pp. 1630-1639
-
-
Bech-Otschir, D.1
Kraft, R.2
Huang, X.3
Henklein, P.4
Kapelari, B.5
Pollmann, C.6
Dubiel, W.7
|